Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
XTuit Pharmaceuticals logo — Pioneering new methods to enhance cancer treatment by focusi...

XTuit Pharmaceuticals

Pioneering new methods to enhance cancer treatment by focusing on the tumor microenvironment.

Founded 2011 Series A Total: $26.00M Biotechnology, Health Care +1

General Information

Company Name XTuit Pharmaceuticals
Founded Year 2011
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series A
Social

Get notified when XTuit Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About XTuit Pharmaceuticals

XTuit Pharmaceuticals is a biotechnology and pharmaceutical company founded in 2011 and based in Waltham, Massachusetts. The company's slogan, "Pioneering new methods to enhance cancer treatment by focusing on the tumor microenvironment," reflects its primary focus on creating advanced pharmaceutical solutions for diagnosing and treating cancer, tumors, and inflammatory diseases. Notably, XTuit Pharmaceuticals received a significant $22.00M Series A investment on 11 June 2015, with contributions from New Enterprise Associates, Polaris Partners, Arcus Ventures, CTI Life Sciences Fund, and Omega Funds. With a clear mission and substantial backing, XTuit Pharmaceuticals is positioned to make an impact in the healthcare and biotechnology industries.

Taxonomy: Pharmaceuticals, Cancer treatment, Tumor microenvironment, Oncological diseases, Inflammatory diseases, Innovative methods, Drug development, Massachusetts, Biopharmaceuticals

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 5
Investor Investor Investor Investor Investor
11 Jun 2015
Venture Round •••••• - 05 Dec 2014

XTuit Pharmaceuticals Alternatives & Competitors

XTuit Pharmaceuticals vs
Cantex Pharmaceuticals, Inc.
Cantex Pharmaceuticals, Inc.

Developing novel treatments of inflammatory diseases and cancer

Debt Financing
3 employees
Biopharma, Biotechnology
XTuit Pharmaceuticals vs
Arriva Pharmaceuticals
Arriva Pharmaceuticals

Pioneering the future of healthcare with innovative protease inhibitors for diverse therapeutic need...

Series D
Health Care, Pharmaceutical
XTuit Pharmaceuticals vs
Fochon Pharmaceuticals
Fochon Pharmaceuticals

Pioneering small molecule therapies for cancer and metabolic illnesses, advancing from discovery to...

11-50 employees
Biotechnology, Health Care

FAQ About XTuit Pharmaceuticals

Pioneering new methods to enhance cancer treatment by focusing on the tumor microenvironment.
XTuit Pharmaceuticals was founded in 2011.
XTuit Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
XTuit Pharmaceuticals has completed 2 funding rounds, raising a total of $26.00M. The latest funding stage is Series A.
Top alternatives and competitors to XTuit Pharmaceuticals include Cantex Pharmaceuticals, Inc., Arriva Pharmaceuticals, Fochon Pharmaceuticals, Acetylon Pharmaceuticals, Inc., Jazz Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
XTuit Pharmaceuticals and Cantex Pharmaceuticals, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors XTuit Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy